 Darleen Sandoval
Concepts (425)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrectomy | 35 | 2022 | 82 | 10.060 |
Why?
| | Glucagon-Like Peptide 1 | 33 | 2022 | 103 | 8.360 |
Why?
| | Bariatric Surgery | 17 | 2022 | 166 | 4.940 |
Why?
| | Glucose | 34 | 2023 | 953 | 4.870 |
Why?
| | Obesity | 46 | 2022 | 2746 | 4.250 |
Why?
| | Weight Loss | 26 | 2022 | 655 | 4.080 |
Why?
| | Blood Glucose | 45 | 2023 | 1939 | 3.860 |
Why?
| | Homeostasis | 25 | 2021 | 594 | 3.640 |
Why?
| | Glucagon-Secreting Cells | 5 | 2023 | 20 | 3.310 |
Why?
| | Gastric Bypass | 10 | 2022 | 93 | 3.130 |
Why?
| | Hypoglycemia | 13 | 2022 | 400 | 3.090 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 19 | 2020 | 75 | 3.060 |
Why?
| | Proglucagon | 9 | 2023 | 9 | 2.870 |
Why?
| | Energy Metabolism | 21 | 2021 | 767 | 2.440 |
Why?
| | Insulin | 37 | 2023 | 2162 | 2.400 |
Why?
| | Hypothalamus | 10 | 2018 | 155 | 2.270 |
Why?
| | Glucagon | 10 | 2021 | 97 | 2.060 |
Why?
| | Diabetes Mellitus, Type 2 | 17 | 2022 | 2174 | 2.030 |
Why?
| | Eating | 21 | 2023 | 369 | 2.030 |
Why?
| | Body Weight | 22 | 2021 | 934 | 1.850 |
Why?
| | Animals | 108 | 2023 | 33381 | 1.780 |
Why?
| | Diabetes Mellitus | 6 | 2021 | 942 | 1.740 |
Why?
| | Receptors, Glucagon | 10 | 2019 | 23 | 1.520 |
Why?
| | Pancreas | 6 | 2021 | 282 | 1.470 |
Why?
| | Diet, High-Fat | 15 | 2021 | 247 | 1.420 |
Why?
| | Neurons | 11 | 2023 | 1345 | 1.400 |
Why?
| | Central Nervous System | 8 | 2014 | 245 | 1.390 |
Why?
| | Rats | 38 | 2022 | 5392 | 1.370 |
Why?
| | Solitary Nucleus | 4 | 2023 | 21 | 1.340 |
Why?
| | Intestinal Mucosa | 6 | 2019 | 531 | 1.270 |
Why?
| | Rats, Long-Evans | 18 | 2020 | 105 | 1.240 |
Why?
| | Incretins | 5 | 2017 | 15 | 1.210 |
Why?
| | Hyperglycemia | 6 | 2023 | 312 | 1.150 |
Why?
| | Leptin | 6 | 2020 | 231 | 1.120 |
Why?
| | Mice | 50 | 2023 | 15520 | 1.090 |
Why?
| | Glucose Tolerance Test | 15 | 2021 | 368 | 1.050 |
Why?
| | Postprandial Period | 7 | 2021 | 96 | 1.040 |
Why?
| | Gastrointestinal Hormones | 2 | 2017 | 8 | 1.030 |
Why?
| | Receptors, Leptin | 4 | 2020 | 27 | 1.020 |
Why?
| | Diet, Fat-Restricted | 3 | 2021 | 76 | 1.020 |
Why?
| | Food Preferences | 6 | 2017 | 119 | 1.010 |
Why?
| | Mice, Knockout | 23 | 2023 | 2680 | 0.990 |
Why?
| | Bile Acids and Salts | 4 | 2022 | 179 | 0.980 |
Why?
| | Insulin-Secreting Cells | 6 | 2021 | 330 | 0.970 |
Why?
| | Stomach | 6 | 2016 | 103 | 0.850 |
Why?
| | Gastrointestinal Tract | 4 | 2019 | 175 | 0.830 |
Why?
| | Brain | 8 | 2018 | 2490 | 0.830 |
Why?
| | Intestines | 3 | 2017 | 332 | 0.790 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2023 | 211 | 0.790 |
Why?
| | Food | 4 | 2017 | 162 | 0.790 |
Why?
| | Signal Transduction | 13 | 2020 | 4709 | 0.760 |
Why?
| | Gastric Inhibitory Polypeptide | 2 | 2019 | 13 | 0.760 |
Why?
| | Male | 65 | 2021 | 57801 | 0.750 |
Why?
| | Pancreatic Hormones | 1 | 2020 | 3 | 0.750 |
Why?
| | Oleic Acids | 1 | 2020 | 13 | 0.740 |
Why?
| | Dipeptidyl Peptidase 4 | 2 | 2019 | 12 | 0.740 |
Why?
| | Ethanolamines | 1 | 2020 | 18 | 0.740 |
Why?
| | Exercise | 7 | 2006 | 1657 | 0.720 |
Why?
| | Endocannabinoids | 1 | 2020 | 37 | 0.720 |
Why?
| | Epinephrine | 9 | 2007 | 167 | 0.710 |
Why?
| | Feeding Behavior | 7 | 2020 | 601 | 0.710 |
Why?
| | Duodenum | 3 | 2022 | 67 | 0.700 |
Why?
| | Fasting | 5 | 2021 | 264 | 0.700 |
Why?
| | Appetite Depressants | 3 | 2018 | 21 | 0.690 |
Why?
| | Sex Characteristics | 3 | 2019 | 671 | 0.690 |
Why?
| | Lipid Metabolism | 5 | 2017 | 477 | 0.690 |
Why?
| | Mice, Inbred C57BL | 19 | 2021 | 4908 | 0.670 |
Why?
| | Gene Expression Regulation | 7 | 2020 | 2445 | 0.670 |
Why?
| | Liver | 6 | 2021 | 1816 | 0.650 |
Why?
| | Peripheral Nervous System | 1 | 2018 | 19 | 0.640 |
Why?
| | Leadership | 1 | 2021 | 311 | 0.630 |
Why?
| | Basal Metabolism | 1 | 2018 | 50 | 0.630 |
Why?
| | Hormones | 6 | 2013 | 135 | 0.630 |
Why?
| | Metabolism | 1 | 2017 | 39 | 0.630 |
Why?
| | Gastric Emptying | 2 | 2016 | 40 | 0.620 |
Why?
| | Diabetes Mellitus, Type 1 | 8 | 2019 | 3360 | 0.610 |
Why?
| | Gastroplasty | 4 | 2022 | 26 | 0.590 |
Why?
| | Anorexia | 2 | 2014 | 18 | 0.570 |
Why?
| | N-Acetylglucosaminyltransferases | 2 | 2022 | 15 | 0.560 |
Why?
| | Peptides | 11 | 2022 | 879 | 0.560 |
Why?
| | Prader-Willi Syndrome | 1 | 2016 | 27 | 0.560 |
Why?
| | Humans | 56 | 2022 | 118974 | 0.550 |
Why?
| | Jejunum | 1 | 2015 | 30 | 0.550 |
Why?
| | Gastric Mucosa | 3 | 2014 | 45 | 0.540 |
Why?
| | Intestinal Absorption | 1 | 2015 | 104 | 0.530 |
Why?
| | Running | 1 | 2018 | 227 | 0.530 |
Why?
| | Disease Models, Animal | 14 | 2021 | 3730 | 0.520 |
Why?
| | Apolipoproteins A | 1 | 2014 | 18 | 0.500 |
Why?
| | Glucose Clamp Technique | 12 | 2015 | 194 | 0.500 |
Why?
| | Hyperphagia | 1 | 2014 | 32 | 0.480 |
Why?
| | Rhombencephalon | 2 | 2018 | 27 | 0.470 |
Why?
| | Venoms | 6 | 2017 | 33 | 0.460 |
Why?
| | Glucokinase | 1 | 2012 | 13 | 0.450 |
Why?
| | Ribosomal Proteins | 1 | 2013 | 68 | 0.450 |
Why?
| | Ileum | 1 | 2013 | 100 | 0.440 |
Why?
| | Vitamin D | 1 | 2016 | 354 | 0.440 |
Why?
| | Hypoglycemic Agents | 10 | 2019 | 1032 | 0.440 |
Why?
| | Malabsorption Syndromes | 2 | 2011 | 15 | 0.440 |
Why?
| | Adaptation, Physiological | 2 | 2015 | 502 | 0.430 |
Why?
| | Triglycerides | 5 | 2021 | 519 | 0.430 |
Why?
| | Malnutrition | 1 | 2013 | 66 | 0.430 |
Why?
| | Estradiol | 2 | 2007 | 476 | 0.430 |
Why?
| | Lipids | 6 | 2021 | 607 | 0.430 |
Why?
| | Emotions | 1 | 2017 | 495 | 0.420 |
Why?
| | Norepinephrine | 8 | 2007 | 212 | 0.420 |
Why?
| | Insulin Resistance | 5 | 2018 | 1180 | 0.400 |
Why?
| | Receptor, Melanocortin, Type 4 | 4 | 2019 | 11 | 0.390 |
Why?
| | Liraglutide | 5 | 2018 | 27 | 0.370 |
Why?
| | Toll-Like Receptor 5 | 1 | 2010 | 15 | 0.370 |
Why?
| | Dexamethasone | 3 | 2017 | 320 | 0.370 |
Why?
| | Dietary Fats | 7 | 2014 | 322 | 0.360 |
Why?
| | Stress, Physiological | 2 | 2003 | 415 | 0.360 |
Why?
| | Fibroblast Growth Factors | 3 | 2022 | 175 | 0.360 |
Why?
| | Receptors, Somatotropin | 2 | 2021 | 9 | 0.350 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2010 | 57 | 0.350 |
Why?
| | Ventromedial Hypothalamic Nucleus | 2 | 2020 | 4 | 0.350 |
Why?
| | Neurosecretory Systems | 2 | 2013 | 33 | 0.340 |
Why?
| | Nicotine | 1 | 2011 | 276 | 0.330 |
Why?
| | Immune System | 1 | 2010 | 181 | 0.330 |
Why?
| | Enteroendocrine Cells | 2 | 2020 | 5 | 0.320 |
Why?
| | Female | 24 | 2021 | 61565 | 0.320 |
Why?
| | Hydrocortisone | 4 | 2005 | 273 | 0.320 |
Why?
| | Prosencephalon | 1 | 2007 | 50 | 0.310 |
Why?
| | Arcuate Nucleus of Hypothalamus | 2 | 2021 | 14 | 0.300 |
Why?
| | Autonomic Nervous System | 3 | 2006 | 66 | 0.300 |
Why?
| | Receptors, Glucocorticoid | 2 | 2008 | 133 | 0.300 |
Why?
| | Body Composition | 7 | 2017 | 653 | 0.290 |
Why?
| | Hyperinsulinism | 6 | 2013 | 107 | 0.280 |
Why?
| | Drug Delivery Systems | 1 | 2009 | 306 | 0.280 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2006 | 28 | 0.280 |
Why?
| | Progesterone | 1 | 2007 | 242 | 0.280 |
Why?
| | Hypoxia | 2 | 2003 | 963 | 0.270 |
Why?
| | Metabolic Syndrome | 1 | 2010 | 394 | 0.270 |
Why?
| | Rats, Sprague-Dawley | 7 | 2008 | 2478 | 0.270 |
Why?
| | Gene Expression | 4 | 2020 | 1489 | 0.270 |
Why?
| | Muscle, Skeletal | 6 | 2021 | 1515 | 0.270 |
Why?
| | Adipose Tissue | 4 | 2021 | 606 | 0.260 |
Why?
| | Lactic Acid | 2 | 2003 | 282 | 0.240 |
Why?
| | Adiposity | 4 | 2019 | 516 | 0.240 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2004 | 44 | 0.240 |
Why?
| | Adipose Tissue, White | 3 | 2020 | 35 | 0.230 |
Why?
| | Smoking | 1 | 2011 | 1487 | 0.230 |
Why?
| | Ghrelin | 2 | 2013 | 30 | 0.230 |
Why?
| | Ethanol | 1 | 2007 | 575 | 0.230 |
Why?
| | Streptozocin | 1 | 2023 | 23 | 0.230 |
Why?
| | Contraceptives, Oral | 1 | 2003 | 27 | 0.220 |
Why?
| | Postoperative Complications | 3 | 2019 | 2235 | 0.220 |
Why?
| | Estrogen Replacement Therapy | 1 | 2003 | 117 | 0.210 |
Why?
| | Gastrointestinal Microbiome | 2 | 2019 | 548 | 0.210 |
Why?
| | Mice, Transgenic | 4 | 2020 | 2025 | 0.210 |
Why?
| | Endocrine Glands | 1 | 2002 | 16 | 0.210 |
Why?
| | Lactobacillus | 1 | 2022 | 23 | 0.210 |
Why?
| | Circadian Rhythm | 4 | 2019 | 401 | 0.210 |
Why?
| | Pancreatitis | 3 | 1997 | 108 | 0.200 |
Why?
| | Adipocytes | 3 | 2019 | 199 | 0.200 |
Why?
| | Glucagon-Like Peptide-2 Receptor | 2 | 2020 | 2 | 0.200 |
Why?
| | Body Mass Index | 2 | 2021 | 2092 | 0.200 |
Why?
| | Nucleus Accumbens | 1 | 2022 | 131 | 0.200 |
Why?
| | Corticosterone | 3 | 2007 | 253 | 0.200 |
Why?
| | Glutamic Acid | 1 | 2022 | 224 | 0.200 |
Why?
| | Energy Intake | 5 | 2018 | 447 | 0.190 |
Why?
| | Ovariectomy | 1 | 2021 | 124 | 0.190 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2020 | 32 | 0.190 |
Why?
| | Scavenger Receptors, Class B | 1 | 2020 | 9 | 0.190 |
Why?
| | Receptors, Calcitonin | 1 | 2020 | 2 | 0.190 |
Why?
| | PPAR alpha | 1 | 2020 | 56 | 0.180 |
Why?
| | Glucose Intolerance | 4 | 2014 | 139 | 0.180 |
Why?
| | Bromocriptine | 1 | 2019 | 28 | 0.180 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2022 | 219 | 0.180 |
Why?
| | Dopamine Agonists | 1 | 2019 | 30 | 0.180 |
Why?
| | Linagliptin | 1 | 2019 | 4 | 0.180 |
Why?
| | Mice, Obese | 2 | 2017 | 58 | 0.180 |
Why?
| | Gene Expression Profiling | 2 | 2019 | 1597 | 0.180 |
Why?
| | Anti-Inflammatory Agents | 1 | 2003 | 465 | 0.180 |
Why?
| | Integrases | 1 | 2020 | 123 | 0.180 |
Why?
| | Pancreas, Exocrine | 1 | 2019 | 8 | 0.180 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2019 | 70 | 0.170 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 44 | 0.170 |
Why?
| | Gene Knockout Techniques | 1 | 2019 | 105 | 0.170 |
Why?
| | Dyslipidemias | 1 | 2020 | 162 | 0.170 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 2016 | 36 | 0.170 |
Why?
| | Bone Resorption | 1 | 2019 | 80 | 0.170 |
Why?
| | Administration, Oral | 2 | 2020 | 756 | 0.170 |
Why?
| | Cardiovascular System | 3 | 2006 | 127 | 0.160 |
Why?
| | Nuclear Proteins | 2 | 2022 | 597 | 0.160 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2020 | 200 | 0.160 |
Why?
| | Bone Marrow Cells | 1 | 2019 | 273 | 0.160 |
Why?
| | Stem Cells | 1 | 2022 | 559 | 0.150 |
Why?
| | Sensation | 1 | 2017 | 43 | 0.150 |
Why?
| | Injections, Intraperitoneal | 1 | 2017 | 108 | 0.150 |
Why?
| | Inflammation | 4 | 2019 | 2566 | 0.150 |
Why?
| | Gene Targeting | 1 | 2017 | 80 | 0.150 |
Why?
| | Diterpenes | 1 | 1996 | 31 | 0.150 |
Why?
| | Immunohistochemistry | 3 | 2016 | 1691 | 0.140 |
Why?
| | Physical Conditioning, Animal | 2 | 2016 | 204 | 0.140 |
Why?
| | Up-Regulation | 1 | 2020 | 872 | 0.140 |
Why?
| | Platelet Activating Factor | 1 | 1996 | 95 | 0.140 |
Why?
| | Organ Specificity | 1 | 2017 | 278 | 0.140 |
Why?
| | Dietary Carbohydrates | 2 | 2014 | 153 | 0.140 |
Why?
| | Neural Pathways | 1 | 2018 | 277 | 0.140 |
Why?
| | Cholesterol | 1 | 2018 | 373 | 0.140 |
Why?
| | Receptors, Calcitriol | 1 | 2016 | 56 | 0.140 |
Why?
| | Electrophysiology | 1 | 2016 | 204 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 982 | 0.140 |
Why?
| | Sex Factors | 1 | 2021 | 1781 | 0.130 |
Why?
| | Diet | 2 | 2021 | 1153 | 0.130 |
Why?
| | Heterozygote | 2 | 2012 | 262 | 0.130 |
Why?
| | Microbiota | 1 | 2022 | 656 | 0.130 |
Why?
| | Lighting | 1 | 2015 | 26 | 0.130 |
Why?
| | Cell Differentiation | 1 | 2022 | 1753 | 0.130 |
Why?
| | MicroRNAs | 1 | 2021 | 637 | 0.120 |
Why?
| | Injections, Intraventricular | 2 | 2004 | 73 | 0.120 |
Why?
| | Receptors, Ghrelin | 1 | 2013 | 7 | 0.120 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2013 | 31 | 0.120 |
Why?
| | Satiation | 1 | 2013 | 24 | 0.120 |
Why?
| | Dietary Proteins | 1 | 2014 | 130 | 0.110 |
Why?
| | Oxygen | 1 | 2018 | 854 | 0.110 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2012 | 11 | 0.110 |
Why?
| | Glucocorticoids | 1 | 2017 | 545 | 0.110 |
Why?
| | Sleep Deprivation | 1 | 2015 | 164 | 0.110 |
Why?
| | Satiety Response | 1 | 2012 | 8 | 0.110 |
Why?
| | Ribonucleotides | 1 | 2012 | 26 | 0.110 |
Why?
| | Diabetes Complications | 1 | 2014 | 218 | 0.110 |
Why?
| | Sympathetic Nervous System | 2 | 2004 | 171 | 0.110 |
Why?
| | Exercise Therapy | 1 | 2016 | 355 | 0.110 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 195 | 0.110 |
Why?
| | Electric Stimulation | 1 | 2013 | 268 | 0.110 |
Why?
| | Weight Gain | 2 | 2016 | 493 | 0.110 |
Why?
| | Pulmonary Gas Exchange | 2 | 2003 | 117 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 333 | 0.110 |
Why?
| | Genetic Markers | 1 | 2013 | 348 | 0.110 |
Why?
| | Peptide YY | 1 | 2011 | 10 | 0.100 |
Why?
| | Macrophages | 2 | 2017 | 1324 | 0.100 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2015 | 280 | 0.100 |
Why?
| | Models, Animal | 1 | 2013 | 363 | 0.100 |
Why?
| | Reference Values | 2 | 2003 | 774 | 0.100 |
Why?
| | Islets of Langerhans | 1 | 2017 | 739 | 0.100 |
Why?
| | Neutrophils | 1 | 1996 | 1233 | 0.100 |
Why?
| | Protein Kinases | 1 | 2012 | 310 | 0.090 |
Why?
| | Apoptosis | 4 | 2013 | 2484 | 0.090 |
Why?
| | Intestine, Small | 2 | 2022 | 131 | 0.090 |
Why?
| | Adult | 10 | 2019 | 31512 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2017 | 2874 | 0.090 |
Why?
| | Synaptic Transmission | 1 | 2011 | 239 | 0.090 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2009 | 28 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2017 | 1774 | 0.090 |
Why?
| | Cell Line, Tumor | 1 | 2016 | 2851 | 0.090 |
Why?
| | Receptors, Nicotinic | 1 | 2011 | 295 | 0.080 |
Why?
| | Bone Marrow | 2 | 2021 | 255 | 0.080 |
Why?
| | HEK293 Cells | 3 | 2017 | 625 | 0.080 |
Why?
| | Phenotype | 1 | 2017 | 3003 | 0.080 |
Why?
| | Appetite Regulation | 1 | 2008 | 26 | 0.080 |
Why?
| | Sympathomimetics | 2 | 2005 | 26 | 0.080 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2008 | 12 | 0.080 |
Why?
| | Glycolysis | 2 | 2021 | 224 | 0.080 |
Why?
| | Disease Susceptibility | 1 | 2010 | 331 | 0.080 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 143 | 0.080 |
Why?
| | Infusions, Parenteral | 1 | 2007 | 37 | 0.080 |
Why?
| | RNA, Messenger | 2 | 2014 | 2657 | 0.080 |
Why?
| | Smoking Cessation | 1 | 2011 | 360 | 0.080 |
Why?
| | Rodentia | 2 | 2019 | 47 | 0.080 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2008 | 167 | 0.070 |
Why?
| | Human Growth Hormone | 2 | 2005 | 37 | 0.070 |
Why?
| | Infusions, Intraventricular | 2 | 2017 | 5 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2016 | 9342 | 0.070 |
Why?
| | Injections, Intravenous | 1 | 2004 | 210 | 0.060 |
Why?
| | Rats, Wistar | 2 | 2016 | 399 | 0.060 |
Why?
| | Consciousness | 1 | 2003 | 21 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2003 | 66 | 0.060 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2022 | 5 | 0.060 |
Why?
| | Pancreatitis-Associated Proteins | 1 | 2022 | 5 | 0.060 |
Why?
| | Infusions, Intravenous | 1 | 2004 | 380 | 0.060 |
Why?
| | Heart Rate | 2 | 2005 | 729 | 0.050 |
Why?
| | Blood Pressure | 3 | 2005 | 1664 | 0.050 |
Why?
| | Glutamine | 1 | 2022 | 88 | 0.050 |
Why?
| | Differential Threshold | 1 | 2002 | 5 | 0.050 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2022 | 155 | 0.050 |
Why?
| | Amino Acid Transport System y+L | 1 | 2020 | 4 | 0.050 |
Why?
| | Epididymis | 1 | 2020 | 9 | 0.050 |
Why?
| | Absorption, Physiological | 1 | 2020 | 5 | 0.050 |
Why?
| | Protein Phosphatase 2C | 1 | 2020 | 14 | 0.050 |
Why?
| | Blood Circulation | 1 | 2020 | 36 | 0.050 |
Why?
| | Respiratory System | 1 | 2002 | 141 | 0.050 |
Why?
| | Ceruletide | 2 | 1997 | 5 | 0.050 |
Why?
| | Kinetics | 1 | 2004 | 1624 | 0.050 |
Why?
| | CLOCK Proteins | 1 | 2019 | 10 | 0.050 |
Why?
| | Oxygen Consumption | 1 | 2003 | 586 | 0.050 |
Why?
| | Exercise Test | 1 | 2003 | 551 | 0.050 |
Why?
| | Prolactin | 1 | 2019 | 96 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2003 | 1293 | 0.040 |
Why?
| | Diet, Reducing | 1 | 2019 | 81 | 0.040 |
Why?
| | Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2018 | 3 | 0.040 |
Why?
| | Vesicular Glutamate Transport Protein 2 | 1 | 2018 | 10 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2008 | 1171 | 0.040 |
Why?
| | Altitude Sickness | 1 | 2000 | 163 | 0.040 |
Why?
| | Colon | 1 | 2020 | 238 | 0.040 |
Why?
| | GABAergic Neurons | 1 | 2018 | 21 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 539 | 0.040 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 38 | 0.040 |
Why?
| | Adenylate Kinase | 1 | 2017 | 29 | 0.040 |
Why?
| | Acute Disease | 2 | 2000 | 940 | 0.040 |
Why?
| | Leukocytes | 1 | 2019 | 290 | 0.040 |
Why?
| | Bone Density | 1 | 2021 | 449 | 0.040 |
Why?
| | Cricetulus | 1 | 2017 | 98 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2018 | 270 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2019 | 298 | 0.040 |
Why?
| | CHO Cells | 1 | 2017 | 143 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 344 | 0.040 |
Why?
| | CD4-CD8 Ratio | 1 | 2017 | 19 | 0.040 |
Why?
| | Pro-Opiomelanocortin | 1 | 2016 | 21 | 0.040 |
Why?
| | Ginkgolides | 1 | 1996 | 4 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1997 | 147 | 0.040 |
Why?
| | Amylases | 1 | 1996 | 14 | 0.040 |
Why?
| | Phosphorylation | 2 | 2018 | 1633 | 0.040 |
Why?
| | Antigens, CD19 | 1 | 1997 | 96 | 0.040 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 1997 | 101 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2020 | 467 | 0.040 |
Why?
| | Tyrosine | 1 | 1997 | 233 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 395 | 0.040 |
Why?
| | Metformin | 1 | 2020 | 295 | 0.040 |
Why?
| | Lipase | 1 | 1996 | 70 | 0.040 |
Why?
| | Lactones | 1 | 1996 | 57 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2003 | 3171 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2018 | 420 | 0.030 |
Why?
| | Adipokines | 1 | 2016 | 46 | 0.030 |
Why?
| | Catecholamines | 1 | 2016 | 100 | 0.030 |
Why?
| | Altitude | 1 | 2000 | 422 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 1997 | 253 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 311 | 0.030 |
Why?
| | Mutation | 2 | 2019 | 3457 | 0.030 |
Why?
| | Pancreatic Ducts | 1 | 1996 | 66 | 0.030 |
Why?
| | Nerve Net | 1 | 2018 | 232 | 0.030 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2014 | 3 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2018 | 653 | 0.030 |
Why?
| | Peptide Hormones | 1 | 2014 | 8 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 287 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2017 | 369 | 0.030 |
Why?
| | Paracrine Communication | 1 | 2014 | 57 | 0.030 |
Why?
| | Cecum | 1 | 2014 | 37 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 551 | 0.030 |
Why?
| | Transcription Factors | 1 | 2022 | 1570 | 0.030 |
Why?
| | Peripheral Nerves | 1 | 2014 | 65 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2013 | 21 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2017 | 442 | 0.030 |
Why?
| | Glucose Transporter Type 4 | 1 | 2013 | 38 | 0.030 |
Why?
| | Tamoxifen | 1 | 2014 | 198 | 0.030 |
Why?
| | Dopamine beta-Hydroxylase | 1 | 2012 | 11 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 1945 | 0.030 |
Why?
| | Food, Formulated | 1 | 2012 | 19 | 0.030 |
Why?
| | Soybean Oil | 1 | 2012 | 12 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2013 | 89 | 0.030 |
Why?
| | Cues | 1 | 2015 | 297 | 0.030 |
Why?
| | Emulsions | 1 | 2012 | 45 | 0.030 |
Why?
| | Organ Size | 1 | 2013 | 460 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2513 | 0.030 |
Why?
| | Sucrose | 1 | 2012 | 104 | 0.030 |
Why?
| | Carnitine | 1 | 2012 | 65 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 1997 | 770 | 0.030 |
Why?
| | Intubation, Gastrointestinal | 1 | 2012 | 61 | 0.030 |
Why?
| | Homozygote | 1 | 2012 | 190 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2012 | 193 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2012 | 176 | 0.020 |
Why?
| | Phospholipids | 1 | 2012 | 208 | 0.020 |
Why?
| | Choice Behavior | 1 | 2012 | 160 | 0.020 |
Why?
| | Agouti-Related Protein | 1 | 2010 | 3 | 0.020 |
Why?
| | Neuropeptide Y | 1 | 2010 | 12 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2012 | 369 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2011 | 128 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1636 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2012 | 371 | 0.020 |
Why?
| | Reward | 1 | 2012 | 209 | 0.020 |
Why?
| | United States | 1 | 2006 | 12555 | 0.020 |
Why?
| | Taste | 1 | 2012 | 218 | 0.020 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2009 | 6 | 0.020 |
Why?
| | Water | 1 | 2012 | 425 | 0.020 |
Why?
| | Chemokine CCL3 | 1 | 2008 | 15 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2012 | 486 | 0.020 |
Why?
| | Receptors, CCR2 | 1 | 2008 | 30 | 0.020 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 55 | 0.020 |
Why?
| | Mesentery | 1 | 2008 | 56 | 0.020 |
Why?
| | Fludrocortisone | 1 | 2008 | 3 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2008 | 126 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 315 | 0.020 |
Why?
| | Piperidines | 1 | 2009 | 171 | 0.020 |
Why?
| | Genotype | 1 | 2012 | 1882 | 0.020 |
Why?
| | Genetic Variation | 1 | 2012 | 926 | 0.020 |
Why?
| | Mitochondria | 1 | 2012 | 786 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2008 | 379 | 0.020 |
Why?
| | Antigens, CD | 1 | 2008 | 460 | 0.020 |
Why?
| | Pyrazoles | 1 | 2009 | 363 | 0.020 |
Why?
| | Pancreatic Polypeptide | 1 | 2005 | 4 | 0.020 |
Why?
| | Calorimetry, Indirect | 1 | 2005 | 72 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 403 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2005 | 736 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 702 | 0.010 |
Why?
| | Biopsy | 1 | 2005 | 1079 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 18480 | 0.010 |
Why?
| | Atmospheric Pressure | 1 | 2000 | 19 | 0.010 |
Why?
| | Drinking | 1 | 2000 | 36 | 0.010 |
Why?
| | Urination | 1 | 2000 | 39 | 0.010 |
Why?
| | Kidney Function Tests | 1 | 2000 | 164 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1715 | 0.010 |
Why?
| | Precipitin Tests | 1 | 1997 | 93 | 0.010 |
Why?
| | Neutralization Tests | 1 | 1997 | 66 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1997 | 53 | 0.010 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 42 | 0.010 |
Why?
| | Biological Assay | 1 | 1997 | 122 | 0.010 |
Why?
| | Cell Separation | 1 | 1997 | 296 | 0.010 |
Why?
| | Opossums | 1 | 1996 | 10 | 0.010 |
Why?
| | Ligation | 1 | 1996 | 82 | 0.010 |
Why?
| | Rabbits | 1 | 1997 | 780 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1996 | 413 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1997 | 341 | 0.010 |
Why?
| | Antibodies | 1 | 1997 | 392 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 827 | 0.010 |
Why?
| | Necrosis | 1 | 1996 | 230 | 0.010 |
Why?
| | Cell Death | 1 | 1996 | 339 | 0.010 |
Why?
| | NF-kappa B | 1 | 1997 | 670 | 0.010 |
Why?
| | DNA Damage | 1 | 1996 | 357 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 1997 | 1067 | 0.010 |
Why?
| | Kidney | 1 | 2000 | 1353 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2000 | 2674 | 0.010 |
Why?
| | Protein Binding | 1 | 1997 | 1975 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1997 | 4077 | 0.010 |
Why?
| | DNA | 1 | 1996 | 1388 | 0.010 |
Why?
|
|
Sandoval's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|